Prof. Matthias P. Schönermark M.D., Ph.D.

Prof. Matthias P. Schönermark, M.D., Ph.D., is a trained head & neck surgeon holding a Ph.D. in molecular oncology. Following his habilitation at MHH in 1998, he changed his position as an Associate Professor at Hannover Medical School to become a project leader & manager at The Boston Consulting Group, where he spent several years, supporting clients in the health care industry in Europe and overseas. In 2005, after a year as Associate Partner with A.T. Kearney, he founded the SKC Beratungsgesellschaft mbH.

He was appointed as Professor of Health Care Management at Hannover Medical School in 2001. He spent several years at Columbia University in New York and at Dartmouth Medical School in Hanover, New Hampshire and lectures at universities & business schools in Europe and the U.S. on strategic issues in health care.

In his function as managing partner at SKC, he is a permanent consultant to numerous leadership personalities of international health insurance and provider organizations, as well as of medtech and pharmaceutical companies on strategic management, innovation management and change management issues.

He holds an unrivalled track record of solving complex and demanding market access challenges, especially in the orphan drug and oncology sector and is one of the most experienced negotiation leaders in reimbursement and pricing for the German AMNOG procedure.

Get in touch

Ihr Ansprechpartner Prof. Matthias P. Schönermark, M.D., Ph.D.
Prof. Matthias P. Schönermark, M.D., Ph.D.
Founder and Managing Director
Fon: +49 511 64 68 14 – 0
Fax: +49 511 64 68 14 18


Prof. Schönermark has published over 300 publications in scientific journals and the general press. Please find below a selection of his current publications. There, you can also find SKC's-publications of recent years.

From innovation to sanctions? (German language only)
Act: Financial Stabilization of the SHI
Successful market access for gene therapies
Routine practice data collection for benefit assessment
A childhood disease comes of age (German language only)
Agile market access

Our Team

Interdisciplinary cooperation enriches our daily work and our clients' results.

Our approach

We improve the situations from patients by creating value in health care.

Eco System

We are opening strategic growth potential for the future with our reliable network.
to the top